HA

Hatteras Venture Partners

VC
Durham, NCWebsite
How to approach: warm intro preferred
Stage

Seed

Check Size

$1.0M – $5.0M

AUM

$900M

Portfolio

5+ companies

Team

6 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Invests in transformative healthcare ventures with a focus on genomics, pediatric innovation, and biotech discoveries.

Meet the Team

LF

Lauren Flickinger

Partner

PJ

Parker Johnson

Director of Investor Relations

FG

Fred Goldwater

Venture Partner

AG

Angelina Green

Executive Assistant

JC

John Crumpler

Manager

CS

Christy Shaffer

Managing Director

Industry Focus

Invests In

Healthcare
Other

Does Not Invest In

Consumer

Portfolio Companies (5)

Other

VI

Viamet Pharmaceuticals

Biotech
GE

GeneCentric Therapeutics

Genomics
HA

Hatteras Opportunity Fund I, LP (CIK 0001903125)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Hatteras Venture Partners

AR

Artizan Biosciences, Inc. (CIK 0001687466)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Hatteras Venture Partners

IL

Ilumivu, Inc. (CIK 0001886001)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Hatteras Venture Partners

Browse More Investors

Frequently Asked Questions

See if Hatteras Venture Partners is a match for your startup

Upload your pitch deck to see how well you match with Hatteras Venture Partners and 200+ other VC firms.